Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor γ in Mouse Liver
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor γ in Mouse Liver
Authors
Keywords
Fatty acids, Lipids, Fatty liver, Oils, Reverse transcriptase-polymerase chain reaction, Gene expression, Messenger RNA, Lipid metabolism
Journal
PLoS One
Volume 11, Issue 11, Pages e0165787
Publisher
Public Library of Science (PLoS)
Online
2016-11-03
DOI
10.1371/journal.pone.0165787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease
- (2016) Fareeba Sheedfar et al. Aging-US
- Prevalence of Nonalcoholic Fatty Liver Disease and Economy
- (2015) Jin-Zhou Zhu et al. DIGESTIVE DISEASES AND SCIENCES
- Role of Mitochondria in Nonalcoholic Fatty Liver Disease
- (2014) Fatiha Nassir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug-Induced Hepatic Steatosis
- (2014) Naga Chalasani et al. SEMINARS IN LIVER DISEASE
- Low-density lipoprotein receptors in liver: Old acquaintances and a newcomer
- (2013) Ursula Pieper-Fürst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Diets and nonalcoholic fatty liver disease: The good and the bad
- (2013) Mohamed Asrih et al. CLINICAL NUTRITION
- Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity
- (2013) Tung-Yuan Shih et al. CURRENT DRUG METABOLISM
- Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
- (2013) Jeff L. Staudinger et al. DRUG METABOLISM REVIEWS
- Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease
- (2013) Carmelo García-Monzón et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
- (2013) Karima Begriche et al. HEPATOLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Activation of Human Stearoyl-Coenzyme A Desaturase 1 Contributes to the Lipogenic Effect of PXR in HepG2 Cells
- (2013) Jun Zhang et al. PLoS One
- Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP
- (2013) Xu Xu et al. SEMINARS IN LIVER DISEASE
- Hepatocyte Growth Factor Protects Against Isoniazid/Rifampicin-Induced Oxidative Liver Damage
- (2013) Cristina Enriquez-Cortina et al. TOXICOLOGICAL SCIENCES
- Fatty acid transport proteins, implications in physiology and disease
- (2011) Melissa Kazantzis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice
- (2011) Xi Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
- (2011) Jinhan He et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
- (2011) M. E. Miquilena-Colina et al. GUT
- SREBPs: metabolic integrators in physiology and metabolism
- (2011) Tae-Il Jeon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte
- (2009) Amélie Moreau et al. HEPATOLOGY
- Regulatory enzymes of mitochondrial β-oxidation as targets for treatment of the metabolic syndrome
- (2009) M. Schreurs et al. Obesity Reviews
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
- (2009) R. L. Silverstein et al. Science Signaling
- Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in mice
- (2009) Xi Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture
- (2008) Chong Shen et al. CELL BIOLOGY AND TOXICOLOGY
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now